Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume 9, Issue 1, Pages 9-20
Publisher
Informa UK Limited
Online
2014-09-01
DOI
10.1586/17474124.2014.953930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?
- (2014) Youngmin A. Lee et al. ANTIVIRAL RESEARCH
- Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection
- (2014) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?
- (2014) Ivan Gentile et al. Expert Review of Anti-Infective Therapy
- Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial
- (2014) Xavier Forns et al. GASTROENTEROLOGY
- Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection
- (2014) Hiromitsu Kumada et al. HEPATOLOGY
- Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial
- (2014) Norio Hayashi et al. JOURNAL OF HEPATOLOGY
- Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2014) Paul M. Scola et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2014) Paul M. Scola et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors
- (2014) Nicola Coppola et al. PLoS One
- Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection
- (2014) Ivan Gentile et al. Therapeutics and Clinical Risk Management
- Evolution of cell culture systems for HCV
- (2013) Deborah R Taylor ANTIVIRAL THERAPY
- Randomized study of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 chronic hepatitis C
- (2013) Jean-Pierre Bronowicki et al. ANTIVIRAL THERAPY
- Emerging treatments for hepatitis C
- (2013) Robert Flisiak et al. EXPERT OPINION ON EMERGING DRUGS
- Sofosbuvir, a nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus infection
- (2013) David Alan Herbst et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection
- (2013) Gregory T. Everson et al. GASTROENTEROLOGY
- Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial
- (2013) Stefan Zeuzem et al. GASTROENTEROLOGY
- Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
- (2013) Donald B. Smith et al. HEPATOLOGY
- Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: The randomized PILLAR study
- (2013) Michael W. Fried et al. HEPATOLOGY
- Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma
- (2013) Yao-Chun Hsu et al. HEPATOLOGY
- Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir
- (2013) Fiona McPhee et al. HEPATOLOGY
- Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics
- (2013) Anuoluwapo Osinusi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dermatological side-effects of telaprevir-based triple therapy for chronic hepatitis C in phase III trials in Japan
- (2013) Hideshi Torii et al. JOURNAL OF DERMATOLOGY
- Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management
- (2013) Jan Peveling-Oberhag et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
- (2013) Eric Lawitz et al. LANCET INFECTIOUS DISEASES
- National Antiviral Treatment Program and the Incidence of Hepatocellular Carcinoma and Associated Mortality in Taiwan
- (2013) Chia-Hsuin Chang et al. MEDICAL CARE
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Profile of alisporivir and its potential in the treatment of hepatitis C
- (2013) Philippe Gallay et al. Drug Design Development and Therapy
- Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential
- (2013) Catherine Stedman Therapeutic Advances in Gastroenterology
- Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)
- (2012) Fiona McPhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C
- (2012) Claudio Pasquinelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir
- (2012) Fiona McPhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets
- (2012) Alexander Ploss et al. GUT
- Current prospects for interferon-free treatment of hepatitis C in 2012
- (2012) Catherine AM Stedman JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir
- (2012) Yoshiyasu Karino et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: A randomized, 28-day, dose-ranging trial
- (2012) Maribel Rodriguez-Torres et al. JOURNAL OF HEPATOLOGY
- Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
- (2012) Yoshiyuki Suzuki et al. JOURNAL OF HEPATOLOGY
- Perspectives and challenges of interferon-free therapy for chronic hepatitis C
- (2012) Christian M. Lange et al. JOURNAL OF HEPATOLOGY
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
- (2011) Kazuaki Chayama et al. HEPATOLOGY
- A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
- (2011) William Sievert et al. LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis C Virus Non-structural Protein 3 (HCV NS3): A Multifunctional Antiviral Target
- (2010) Kevin D. Raney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Critical Role of Cyclophilin A and Its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the Hepatitis C Virus Replication Complex
- (2009) Z. Liu et al. JOURNAL OF VIROLOGY
- Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3
- (2009) V. Schregel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatitis C virus hijacks host lipid metabolism
- (2009) Gulam H. Syed et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Pegylated Interferon‐α‐2a plus Ribavirin for Treatment‐Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial
- (2008) Chen‐Hua Liu et al. CLINICAL INFECTIOUS DISEASES
- Hepatitis C genotype 4: What we know and what we don't yet know
- (2008) Sanaa M. Kamal et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now